All the latest packaging trends for life sciences, all at PACK EXPO East
Explore new packaging solutions for life sciences, all in one convenient location at PACK EXPO East, March 18 – 20 in Philadelphia.

Court halts sale of first FDA-approved biosimilar

The sale of Sandoz's biosimilar version of Amgen Inc,'s drug Neupogen is on hold.

Hold your biosimilar horses.

A judge has temporarly blocked the sale of Sandoz's biosimilar version of Amgen Inc,'s drug Neupogen.

Approved by the FDA in March, and the drug is the first biosimilar to be sold in the U.S., but a U.S. Court of Appeals for the Federal Circuit issued an injunction preventing the sale until the court resolves a pending appeal over the medication's release, reported The Recorder.

"In seeking the injunction from the Federal Circuit, lawyers for Amgen argued that the case presents issues of first impression under the 2010 Biologics Price Competition and Innovation Act, which created a new pathway for the approval of biosimilar products," wrote The Recorder. "Argument is set for June 3."

Discover the right packaging solutions for life sciences in Philadelphia
Explore innovative packaging and supply chain solutions for the life sciences at the largest PACK EXPO East in history, March 18–20. Get ideas from 400+ top exhibitors and connect with colleagues and industry experts—all in one convenient location!
Read More
Discover the right packaging solutions for life sciences in Philadelphia
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts